Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials

ClinicalLIVEUpdated 18 Nov 2026

New Clinical Trials

Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.

Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.

Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777

Signals

What the register says this week, and why it matters if you sell into it.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
  3. 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
  4. A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

Export the full new clinical trials

777 rows as a .csv. Free. Every field, with its source link.

Country
Phase 1
Study type
208 / 777 trials
PostedSponsorStudyPhaseStatus
29 Oct 2026Guangdong ProCapZoom Biosciences Co., Ltd.A Clinical Study to Evaluate the Safety and Effectiveness of MSCohi-O Lens in the Treatment of Immune-related Ocular Surface Diseases.Phase 1Not Yet Recruiting29 Oct 2026Guizhou Sinorda Pharmaceutical Co., Ltd.ChinaSND002 Cell Injection in Participants With Advanced Malignant Solid TumorsPhase 1Not Yet Recruiting29 Oct 2026Innovent Biologics (Suzhou) Co. Ltd.ChinaA Study of IBI3043 Treatment in Participants With Locally Advanced, Unresectable or Metastatic Solid TumorsPhase 1Not Yet Recruiting29 Oct 2026Mabsoft Therapeutics (Shanghai) Co., Ltd.AustraliaPhase Ia Study of MST-931 in Healthy Adult SubjectsPhase 1Recruiting29 Oct 2026North Immunology Inc.AustraliaA Study of NOR-101 in Healthy Adults and Adults With Moderate-to-Severe Atopic DermatitisPhase 1Not Yet Recruiting29 Oct 2026PfizerUnited StatesA Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.Phase 1Recruiting29 Oct 2026Prelude Therapeutics IncorporatedUnited StatesA Phase 1/1b Study of PRT13722 in Participants With Advanced HR+/HER2- Breast CancerPhase 1Recruiting29 Oct 2026Shanghai YingLi Pharmaceutical Co. Ltd.First-in-Human, Multicenter, Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of YL-18319 Monotherapy in Patients With Locally Advanced/Metastatic Solid TumorsPhase 1Not Yet Recruiting29 Oct 2026Sinocelltech Ltd.ChinaPhase Ia/Ib Trial of SCTA02A Injection in Healthy Adults and Patients With Chronic Hepatitis BPhase 1Not Yet Recruiting29 Oct 2026Superluminal Medicines, Inc.A Study of Safety of SUN-0864 and How it is Processed by and Affects the Body in Healthy Adults and Healthy Adults Who Are Overweight or Obese.Phase 1Not Yet Recruiting28 Oct 2026AJU Pharm Co., Ltd.South KoreaA Bioequivalence and Safety Study of AJU-B718 and B718R in Healthy Adult Volunteers Under Fasting ConditionsPhase 1Not Yet Recruiting28 Oct 2026AJU Pharm Co., Ltd.South KoreaA Bioequivalence and Safety Study of AJU-C719 and C719R in Healthy Adult VolunteersPhase 1Not Yet Recruiting28 Oct 2026Anhui HygeianCells BioMedical Co., Ltd.ChinaA Single-Center Phase 1 Study of ceAF for Knee Osteoarthritis (KOA)Phase 1Recruiting28 Oct 2026Cajal Therapeutics Inc.AustraliaStudy of CTX001 in Adults With Anemia Due to Non-Dialysis-Dependent Chronic Kidney DiseasePhase 1Not Yet Recruiting28 Oct 2026Helixon Biotechnology (Suzhou) Co., LtdAustraliaStudy of HXN-1013 in Healthy Participants and Participants With Mild-to-Moderate AsthmaPhase 1Not Yet Recruiting28 Oct 2026Keymed Biosciences Co.LtdChinaStudy of Single and Multiple Ascending Doses of CM551 in Healthy ParticipantsPhase 1Not Yet Recruiting28 Oct 2026Odyssey Therapeutics, Inc.United KingdomThe Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]OD-001 in Healthy Male ParticipantsPhase 1Recruiting28 Oct 2026Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd.AustriaPhase 1 Study to Evaluate RG002C0106 Injection in Healthy ParticipantsPhase 1Not Yet Recruiting27 Oct 2026Axter Therapeutics (Beijing) Co., LtdChinaAXT-1003 Combination With Enzalutamide in Participants With mCRPCPhase 1Recruiting27 Oct 2026BeOne MedicinesA First-in-Human Study of BG-92505 Alone or in Combination With Other Anti-cancer Agents in Patients With Advanced Solid TumorsPhase 1Not Yet Recruiting27 Oct 2026Desentum OyGermanySafety, Tolerability And Pharmacodynamics of DM-101PX in Birch Pollen AllergyPhase 1Recruiting27 Oct 2026Hansoh BioMedical R&D CompanyA Phase I Study of HS-20093 Injection in Combination Therapy in Non-Small Cell Lung CancerPhase 1Not Yet Recruiting27 Oct 2026Jiangsu Hansoh Pharmaceutical Co., Ltd.ChinaA Study to Evaluate the Pharmacokinetic Characteristics of HS-20118 Under Different Dosing Conditions in Healthy ParticipantsPhase 1Active Not Recruiting27 Oct 2026Metaclipse Therapeutics CorporationUnited StatesTMV Vaccine Alone or With Toripalimab-tpzi for Recurrent Head and Neck Squamous Cell CarcinomaPhase 1Recruiting27 Oct 2026PfizerUnited States, Puerto RicoA Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid TumorsPhase 1Not Yet Recruiting27 Oct 2026PfizerA Study to Learn How Different Amounts of the Study Medicine Called PF-08161842 Are Tolerated and Act in the Body in Healthy and Older AdultsPhase 1Not Yet Recruiting27 Oct 2026Pneumagen Ltd, a subsidiary of NorthLinks BioUnited KingdomNasal Residency of HEX17Phase 1Not Yet Recruiting27 Oct 2026Triastek, lnc.ChinaA Food-Effect Study of Budesonide Delayed Release Tablet (D23A) in Healthy Chinese ParticipantsPhase 1Not Yet Recruiting26 Oct 2026BeOne MedicinesAn Investigational Study of BON-106 in Adults With Advanced or Metastatic Solid TumorsPhase 1Not Yet Recruiting26 Oct 2026InventisBio Yiqi Beijing LimitedA Study to Evaluate YF550 in Participants With Locally Advanced or Metastatic Solid Tumors.Phase 1Not Yet Recruiting26 Oct 2026Novo Nordisk A/SGermanyA Research Study to Check the Safety of NNC9836-0001 When Given to Healthy Participants and Participants With Type 2 DiabetesPhase 1Recruiting26 Oct 2026Nuwacell Biotechnologies Co., Ltd.ChinaA Phase 1 Study of NCR201 in Parkinson's Disease Patients With Prior DBSPhase 1Not Yet Recruiting23 Oct 2026Ascletis Pharma (China) Co., LimitedUnited StatesA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC36 Tablets for Oral Use in Adult Participants With Obesity or OverweightPhase 1Recruiting23 Oct 2026Ascletis Pharma (China) Co., LimitedUnited StatesA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Formulations of ASC36 Injection in Participants With Obesity or OverweightPhase 1Recruiting23 Oct 2026BioNTech SEA First-in-human Clinical Trial to Test if the Investigational Drug BNT3219 is Safe and Potentially Beneficial for People With Advanced Solid Tumors When Given Alone or Together With Other Investigational DrugsPhase 1Not Yet Recruiting23 Oct 2026GuangZhou Cellgenes Biotechnology Co., Ltd.ChinaClinical Trial of CG-BM1 Allogeneic Human Bone Marrow Mesenchymal Stem Cell Injection in the Treatment of Acute Respiratory Distress SyndromePhase 1Completed23 Oct 2026Hansoh BioMedical R&D CompanyA Phase I Study of HS-20093 in Combination With ZG006 With or Without Adebrelimab in Patients With ES-SCLCPhase 1Not Yet Recruiting22 Oct 2026Aktis Oncology, Inc.United StatesA Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid TumorsPhase 1Recruiting22 Oct 2026Bavarian NordicUnited StatesPhase 1 Trial to Evaluate Safety and Immunogenicity of MVA-BN-EBV in Healthy Young AdultsPhase 1Not Yet Recruiting22 Oct 2026Beijing Suncadia Pharmaceuticals Co., LtdChinaA Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SHR 3201 Injection in Healthy ParticipantsPhase 1Not Yet Recruiting22 Oct 2026Dizal PharmaceuticalsChinaAssessing the Effect of a Proton Pump Inhibitor on the Pharmacokinetics of DZD8586 in Healthy Participants (TAI-SHAN21)Phase 1Recruiting22 Oct 2026iBio, Inc.AustraliaA Study to Evaluate a Single Dose of IBIO-610 in Participant With Obesity.Phase 1Not Yet Recruiting22 Oct 2026Immunome, Inc.A Phase 1 Study of IM-1340 in Participants With Advanced CancerPhase 1Not Yet Recruiting22 Oct 2026Sinovac Biotech Co., LtdChinaPhase I Clinical Trial of Trivalent Inactivated Split Influenza Virus Vaccine (MDCK Cell)Phase 1Not Yet Recruiting21 Oct 2026Antido Therapeutics (Australia) Pty LtdAustraliaSafety and Tolerability of AT-0174 in Adults With Advanced Solid TumorsPhase 1Completed21 Oct 2026Ausper Biopharma Co., Ltd.ChinaA Clinical Study of AHB-121 in Healthy Participants and Chronic Hepatitis B (CHB) ParticipantsPhase 1Not Yet Recruiting21 Oct 2026BeOne MedicinesA Study Investigating the Safety and How the Trispecific T-Cell Engaging Antibody BG-T0920 Works in Adults With Diffuse Large B-cell Lymphoma (DLBCL) and Other Aggressive B-Cell MalignanciesPhase 1Not Yet Recruiting21 Oct 2026Bristol-Myers SquibbUnited StatesA Phase 1 Study to Evaluate Safety, Tolerability, and Drug Levels of BMS-986485 in Healthy Adult ParticipantsPhase 1Not Yet Recruiting21 Oct 2026Ethyreal Bio, Inc.United StatesEvaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye DiseasePhase 1Recruiting21 Oct 2026GRIN Therapeutics, Inc.United StatesA Study to Evaluate the Effect of Carbamazepine or Itraconazole on Radiprodil in Healthy Adult ParticipantsPhase 1Active Not Recruiting

// How AOS uses this

Every row here is a potential account. AOS finds the ones that need what you sell, maps the decision makers and prepares the outreach for your approval.